Xencor XNCR
NASDAQ XNCR
$26.61 -0.01 (-0.04%)
As of: Sep 4, 2026 · 3:59 PM EDT

Xencor (XNCR) Change in Account Payables (2013 - 2026)

Xencor (XNCR) posted quarterly Change in Account Payables of -$2.9 million for Q1 2026, down 405.46% year-over-year from $939900.9 in Q1 2025, and down 269.78% quarter-over-quarter from $1.7 million in Q4 2025.

Analysis

Xencor (XNCR) Change in Account Payables (2013 - 2026) Analysis & Trends

Xencor (XNCR) has reported Change in Account Payables for 14 consecutive years, with -$2.9 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Change in Account Payables fell 405.46% year-over-year to -$2.9 million; the TTM figure through Mar 2026 stood at -$6.3 million (down 3575.56% YoY), while the FY2025 annual figure was -$4.0 million, down 238.95% from the prior year.
  • Change in Account Payables slipped to -$2.9 million in Q1 2026 per XNCR's latest filing, from $1.7 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $5.3 million in Q1 2023 and bottomed at -$9.5 million in Q3 2025.
  • Historically, Change in Account Payables has averaged -$239176.5 across 5 years, with a median of -$568000.0 in 2025.
  • On a YoY basis, Change in Account Payables climbed as much as 2630.64% in 2025 and fell as far as 422.44% in 2025.
  • Xencor's Change in Account Payables stood at -$4.5 million in 2022, then jumped by 76.75% to -$1.1 million in 2023, then sank by 90.98% to -$2.0 million in 2024, then surged by 184.09% to $1.7 million in 2025, then tumbled by 269.78% to -$2.9 million in 2026.
  • Business Quant data shows XNCR's Change in Account Payables at -$2.9 million in Q1 2026, $1.7 million in Q4 2025, and -$9.5 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -66.70 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -8.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 5.03 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 37.53 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Xencor 2.02 Bn 1.65 Bn - 4.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.51 Mn
Mar 31, 2026 -2.87 Mn
Dec 31, 2025 1.69 Mn
Sep 30, 2025 -9.45 Mn
Jun 30, 2025 4.38 Mn
Mar 31, 2025 -568,000.00
Dec 31, 2024 -2.01 Mn
Sep 30, 2024 2.93 Mn
Jun 30, 2024 -173,000.00
Mar 31, 2024 2.10 Mn
Dec 31, 2023 -1.05 Mn
Sep 30, 2023 870,000.00
Jun 30, 2023 -1.25 Mn
Mar 31, 2023 5.25 Mn
Dec 31, 2022 -4.53 Mn
Sep 30, 2022 -1.13 Mn
Jun 30, 2022 3.84 Mn
Mar 31, 2022 -2.10 Mn
Dec 31, 2021 4.87 Mn
Sep 30, 2021 2.02 Mn